MediumHaematologyVTE prophylaxis in patients on anticoagulationau-amcau-racp
A 70-year-old woman with non-valvular atrial fibrillation and previous unprovoked deep vein thrombosis is admitted to hospital with pneumonia. She is on apixaban for stroke prevention and VTE. When considering VTE prophylaxis, which statement best reflects Australian guidance?